MAPK3 and synovial sarcoma: Subsequently, an in vitro SS inflammation model was constructed by stimulating SMG-C6 cells with 50 ng/mL IFN-γ for 24 h (18) to investigate the effect of the MAPK3 inhibitor U0126.